{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:37:01Z","timestamp":1787870221313,"version":"build-2784847793"},"reference-count":34,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PPA"],"DOI":"10.2147\/ppa.s345906","type":"journal-article","created":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T10:20:08Z","timestamp":1646130008000},"page":"573-585","source":"Crossref","is-referenced-by-count":15,"title":["Preferences and Priorities for Relapsed Multiple Myeloma Treatments Among Patients and Caregivers in the United States"],"prefix":"10.2147","volume":"Volume 16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5151-3058","authenticated-orcid":true,"given":"Daniel","family":"Auclair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3144-8938","authenticated-orcid":true,"given":"Carol","family":"Mansfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A","family":"Fiala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajai","family":"Chari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig E","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan L","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J","family":"Orloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3604-2574","authenticated-orcid":true,"given":"David S","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A","family":"Zonder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brennan","family":"Mange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Yesil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehul","family":"Dalal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R","family":"Mikhael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,3]]},"reference":[{"key":"ref1","unstructured":"National Cancer Institute Surveillance, Epidemiology, and End Results Program (NCI SEER). Cancer stat facts: multiple myeloma. Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/mulmy.html. Accessed June 3, 2019."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1053\/j.seminoncol.2016.11.004","volume":"43","author":"Kazandjian","year":"2016","journal-title":"Semin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ejh.12882","volume":"99","author":"Nielsen","year":"2017","journal-title":"Eur J Haematol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1158\/0008-5472.CAN-15-3545","volume":"77","author":"Hiasa","year":"2017","journal-title":"Cancer Res"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.2215\/CJN.12231212","volume":"8","author":"Heher","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref6","first-page":"155","volume":"104","author":"Tzoran","year":"2013","journal-title":"Minerva Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jpainsymman.2012.11.003","volume":"46","author":"Boland","year":"2013","journal-title":"J Pain Symptom Manage"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1182\/blood.V112.11.2366.2366","volume":"112","author":"Muehlbacher","year":"2008","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2020.09.010","author":"Mian","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1080\/07347332.2015.1019660","volume":"33","author":"Deniz","year":"2015","journal-title":"J Psychosoc Oncol"},{"key":"ref11","unstructured":"Multiple Myeloma Research Foundation (MMRF). MMRF CoMMpass Study. Available from: https:\/\/themmrf.org\/we-are-curing-multiple-myeloma\/mmrf-commpass-study\/. Accessed November 7, 2019."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jval.2010.11.013","volume":"14","author":"Bridges","year":"2011","journal-title":"Value Health"},{"key":"ref13","unstructured":"Chrzan K, Orme B. An overview and comparison of design strategies for choice-based conjoint analysis. Technical Paper Series. Sawtooth Software Inc; 2000."},{"key":"ref14","volume-title":"Marketing Research Methods in SAS: Experimental Design, Choice, Conjoint, and Graphical Techniques","year":"2010"},{"key":"ref15","unstructured":"Kuhfeld W. Efficient experimental designs using computerized searches. Sawtooth Software Conference Proceedings; 1997:71\u201386."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1177\/002224379403100408","volume":"31","author":"Kuhfeld","year":"1994","journal-title":"J Mark Res"},{"key":"ref17","unstructured":"Sawtooth Software Inc. CBC User Manual. Sequim: Sawtooth Software; 1999."},{"key":"ref18","volume-title":"Discrete Choice Methods with Simulation","year":"2009"},{"key":"ref19","volume-title":"Applications of Simulation Methods in Environmental and Resource Economics","year":"2005"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jval.2016.04.004","volume":"19","author":"Hauber","year":"2016","journal-title":"Value Health"},{"key":"ref21","unstructured":"Food and Drug Administration (FDA). Prescription Drug User Fee Act (PDUFA) VI. Available from: https:\/\/www.fda.gov\/ForIndustry\/UserFees\/PrescriptionDrugUserFee\/. Accessed June 25, 2018."},{"key":"ref22","unstructured":"Food and Drug Administration (FDA). 21st century cures act; 2018. Available from: https:\/\/www.fda.gov\/RegulatoryInformation\/LawsEnforcedbyFDA\/SignificantAmendmentstotheFDCAct\/21stCenturyCuresAct\/default.htm. Accessed June 25, 2018."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.2147\/PPA.S259612","volume":"14","author":"Fifer","year":"2020","journal-title":"Patient Prefer Adherence"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1186\/s12885-020-07018-6","volume":"20","author":"Fifer","year":"2020","journal-title":"BMC Cancer"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S1470-2045(11)70081-X","volume":"12","author":"Moreau","year":"2011","journal-title":"Lancet Oncol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.2217\/fon-2018-0871","volume":"15","author":"Mansfield","year":"2019","journal-title":"Future Oncol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1182\/bloodadvances.2017007294","volume":"1","author":"Mansfield","year":"2017","journal-title":"Blood Adv"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.2147\/PPA.S106629","volume":"10","author":"Eek","year":"2016","journal-title":"Patient Prefer Adherence"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.lungcan.2012.01.016","volume":"77","author":"Bridges","year":"2012","journal-title":"Lung Cancer"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.2147\/PPA.S183187","volume":"12","author":"Wilke","year":"2018","journal-title":"Patient Prefer Adherence"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1634\/theoncologist.2018-0724","volume":"24","author":"Chari","year":"2019","journal-title":"Oncologist"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12885-019-5467-x","volume":"19","author":"Parsons","year":"2019","journal-title":"BMC Cancer"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Romanus D, DasMahapatra P, Hoole M, et al. Treatment satisfaction and burden of illness with oral vs injectable therapy in patients with relapsed\/refractory multiple myeloma (RRMM). Poster presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 22nd Annual International Meeting; May 20\u201324, 2017; Boston, Massachusetts.","DOI":"10.1016\/j.jval.2017.08.315"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1182\/blood-2021-152648","volume":"138","author":"Fleischer","year":"2021","journal-title":"Blood"}],"container-title":["Patient Preference and Adherence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=78725","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=78725","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T10:20:15Z","timestamp":1646130015000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/preferences-and-priorities-for-relapsed-multiple-myeloma-treatments-am-peer-reviewed-fulltext-article-PPA"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":34,"URL":"https:\/\/doi.org\/10.2147\/ppa.s345906","relation":{},"ISSN":["1177-889X"],"issn-type":[{"value":"1177-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3]]}}}